Michael Mendicino

Michael Mendicino, Ph.D. is the President and Owner of Hybrid Concepts International, LLC, a consulting firm specializing in cell therapy and regenerative medicine since 2016. With experience on various advisory boards, Mendicino is currently a member of the Scientific Advisory Board for RoslinCT and serves as Chair of the Regulatory CMC Task Force for the Alliance for Regenerative Medicine. As a co-founder and board member of the Standards Coordinating Body, Mendicino plays a significant role in establishing standards in regenerative therapies. Previous positions include roles in regulatory affairs at Mesoblast, MaxCyte, RoosterBio, and serving as an FDA Commissioner's Fellow. Mendicino holds a Ph.D. in Immunology from the University of Toronto and multiple qualifications in regulatory sciences and business administration.